Abstract
Protein arginine deiminases (PADs) catalyze the post-translational deimination of peptidyl arginine to form peptidyl citrulline. This modification is increased in multiple inflammatory diseases and in certain cancers. PADs regulate a variety of signaling pathways including apoptosis, terminal differentiation, and transcriptional regulation. Activity-based protein profiling (ABPP) probes have been developed to understand the role of the PADs in vivo and to investigate the effect of protein citrullination in various pathological conditions. Furthermore, these ABPPs have been utilized as a platform for high-throughput inhibitor discovery. This review will showcase the development of ABPPs targeting the PADs. In addition, it provides a brief overview of PAD structure and function along with recent advances in PAD inhibitor development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharya NK, Nagele EP, Han M, Coretti NJ, DeMarshall C, Kosciuk MC, Boulos PA, Nagele RG (2012) Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J Autoimmun 38(4):369–380. https://doi.org/10.1016/j.jaut.2012.03.004
Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M (2004) Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11(8):777–783. https://doi.org/10.1038/nsmb799
Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M, Sato M (2006) Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc Natl Acad Sci U S A 103(14):5291–5296. https://doi.org/10.1073/pnas.0509639103
Bawadekar M, Gendron-Fitzpatrick A, Rebernick R, Shim D, Warner TF, Nicholas AP, Lundblad LK, Thompson PR, Shelef MA (2016) Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation. Arthritis Res Ther 18(1):173. https://doi.org/10.1186/s13075-016-1068-0
Bicker KL, Anguish L, Chumanevich AA, Cameron MD, Cui X, Witalison E, Subramanian V, Zhang X, Chumanevich AP, Hofseth LJ et al (2012a) d-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy. ACS Med Chem Lett 3(12):1081–1085. https://doi.org/10.1021/ml300288d
Bicker KL, Subramanian V, Chumanevich AA, Hofseth LJ, Thompson PR (2012b) Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. J Am Chem Soc 134(41):17015–17018. https://doi.org/10.1021/ja308871v
Bicker KL, Thompson PR (2013) The protein arginine deiminases: Structure, function, inhibition, and disease. Biopolymers 99(2):155–163. https://doi.org/10.1002/bip.22127
Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, Bicker KL, Wahamaa H, Hoffmann V et al (2017) Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci Immunol 2(10). https://doi.org/10.1126/sciimmunol.aag3358
Causey CP, Jones JE, Slack JL, Kamei D, Jones LE, Subramanian V, Knuckley B, Ebrahimi P, Chumanevich AA, Luo Y et al (2011) The development of N-alpha-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-alpha-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors. J Med Chem 54(19):6919–6935. https://doi.org/10.1021/jm2008985
Cherrington BD, Morency E, Struble AM, Coonrod SA, Wakshlag JJ (2010) Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones. PLoS ONE 5(7):e11768. https://doi.org/10.1371/journal.pone.0011768
Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, Mowen KA, Bertone P, Silva JC, Zernicka-Goetz M et al (2014) Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507(7490):104–108. https://doi.org/10.1038/nature12942
Chumanevich AA, Causey CP, Knuckley BA, Jones JE, Poudyal D, Chumanevich AP, Davis T, Matesic LE, Thompson PR, Hofseth LJ (2011) Suppression of Colitis in Mice by Cl-Amidine: a novel Peptidylarginine Deiminase (Pad) Inhibitor. Am J Physiol Gastrointest Liver Physiol 300(6):G929–G938. https://doi.org/10.1152/ajpgi.00435.2010
Clancy KW, Russell AM, Subramanian V, Nguyen H, Qian Y, Campbell RM, Thompson PR (2017) Citrullination/methylation crosstalk on Histone H3 regulates ER-target gene transcription. ACS Chem Biol 12(6):1691–1702. https://doi.org/10.1021/acschembio.7b00241
De Ceuleneer M, De Wit V, Van Steendam K, Van Nieuwerburgh F, Tilleman K, Deforce D (2011) Modification of citrulline residues with 2,3-butanedione facilitates their detection by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 25(11):1536–1542. https://doi.org/10.1002/rcm.5015
Dreyton CJ, Anderson ED, Subramanian V, Boger DL, Thompson PR (2014a) Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. Bioorg Med Chem 22(4):1362–1369. https://doi.org/10.1016/j.bmc.2013.12.064
Dreyton CJ, Knuckley B, Jones JE, Lewallen DM, Thompson PR (2014b) Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism. Biochemistry 53(27):4426–4433. https://doi.org/10.1021/bi500554b
Esposito G, Vitale AM, Leijten FP, Strik AM, Koonen-Reemst AM, Yurttas P, Robben TJ, Coonrod S, Gossen JA (2007) Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol Cell Endocrinol 273(1–2):25–31. https://doi.org/10.1016/j.mce.2007.05.005
Fuhrmann J, Clancy KW, Thompson PR (2015) Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev 115(11):5413–5461. https://doi.org/10.1021/acs.chemrev.5b00003
Fuhrmann J, Thompson PR (2016) Protein arginine methylation and citrullination in epigenetic regulation. ACS Chem Biol 11(3):654–668. https://doi.org/10.1021/acschembio.5b00942
Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B et al (2016) Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Sci Adv 2(2):e1501257. https://doi.org/10.1126/sciadv.1501257
Holm A, Rise F, Sessler N, Sollid LM, Undheim K, Fleckenstein B (2006) Specific modification of peptide-bound citrulline residues. Anal Biochem 352(1):68–76. https://doi.org/10.1016/j.ab.2006.02.007
Horibata S, Vo TV, Subramanian V, Thompson PR, Coonrod SA (2015) Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J Vis Exp (99):e52727. https://doi.org/10.3791/52727
Ishida-Yamamoto A, Senshu T, Eady RA, Takahashi H, Shimizu H, Akiyama M, Iizuka H (2002) Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination. J Invest Dermatol 118(2):282–287. https://doi.org/10.1046/j.0022-202x.2001.01671.x
Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N et al (2005) Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer’s disease. J Neurosci Res 80(1):120–128. https://doi.org/10.1002/jnr.20431
Jamali H, Khan HA, Stringer JR, Chowdhury S, Ellman JA (2015) Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method. J Am Chem Soc 137(10):3616–3621. https://doi.org/10.1021/jacs.5b00095
Jamali H, Khan HA, Tjin CC, Ellman JA (2016) Cellular activity of new small molecule protein arginine deiminase 3 (PAD3) inhibitors. ACS Med Chem Lett 7(9):847–851. https://doi.org/10.1021/acsmedchemlett.6b00215
Jang B, Kim E, Choi JK, Jin JK, Kim JI, Ishigami A, Maruyama N, Carp RI, Kim YS, Choi EK (2008) Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol 173(4):1129–1142. https://doi.org/10.2353/ajpath.2008.080388
Jang B, Shin HY, Choi JK, du Nguyen PT, Jeong BH, Ishigami A, Maruyama N, Carp RI, Kim YS, Choi EK (2011) Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction- enriched citrullinated proteins. J Neuropathol Exp Neurol 70(2):116–124. https://doi.org/10.1097/NEN.0b013e318207559e
Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, Thompson PR (2009) Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 12(5):616–627
Jones JE, Slack JL, Fang P, Zhang X, Subramanian V, Causey CP, Coonrod SA, Guo M, Thompson PR (2012) Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors. ACS Chem Biol 7(1):160–165. https://doi.org/10.1021/cb200258q
Kan R, Jin M, Subramanian V, Causey CP, Thompson PR, Coonrod SA (2012) Potential role for PADI-mediated histone citrullination in preimplantation development. BMC Dev Biol 1219. https://doi.org/10.1186/1471-213x-12-19
Kawalkowska J, Quirke AM, Ghari F, Davis S, Subramanian V, Thompson PR, Williams RO, Fischer R, La Thangue NB, Venables PJ (2016) Abrogation of collagen–induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci Rep 626430. https://doi.org/10.1038/srep26430
Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V et al (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5(178):178ra140. https://doi.org/10.1126/scitranslmed.3005580
Knight JS, Luo W, O’Dell AA, Yalavarthi S, Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT et al (2014) Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res 114(6):947–956. https://doi.org/10.1161/CIRCRESAHA.114.303312
Knight JS, Subramanian V, O’Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ (2015) Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis 74(12):2199–2206. https://doi.org/10.1136/annrheumdis-2014-205365
Knight JS, Zhao W, Luo W, Subramanian V, O’Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ (2013) Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 123(7):2981–2993. https://doi.org/10.1172/JCI67390
Knuckley B, Bhatia M, Thompson PR (2007) Protein arginine deiminase 4: evidence for a reverse protonation mechanism. Biochemistry 46(22):6578–6587. https://doi.org/10.1021/bi700095s
Knuckley B, Causey CP, Jones JE, Bhatia M, Dreyton CJ, Osborne TC, Takahara H, Thompson PR (2010a) Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry 49(23):4852–4863. https://doi.org/10.1021/bi100363t
Knuckley B, Causey CP, Pellechia PJ, Cook PF, Thompson PR (2010b) Haloacetamidine- based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation. ChemBioChem 11(2):161–165. https://doi.org/10.1002/cbic.200900698
Knuckley B, Jones JE, Bachovchin DA, Slack J, Causey CP, Brown SJ, Rosen H, Cravatt BF, Thompson PR (2010c) A fluopol-ABPP HTS assay to identify PAD inhibitors. Chem Commun (Camb) 46(38):7175–7177. https://doi.org/10.1039/c0cc02634d
Knuckley B, Luo Y, Thompson PR (2008) Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors. Bioorg Med Chem 16(2):739–745. https://doi.org/10.1016/j.bmc.2007.10.021
Lange S, Gogel S, Leung KY, Vernay B, Nicholas AP, Causey CP, Thompson PR, Greene ND, Ferretti P (2011) Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. Dev Biol 355(2):205–214. https://doi.org/10.1016/j.ydbio.2011.04.015
Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188(7):3522–3531. https://doi.org/10.4049/jimmunol.1102404
Lewallen DM, Bicker KL, Madoux F, Chase P, Anguish L, Coonrod S, Hodder P, Thompson PR (2014) A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs. ACS Chem Biol 9(4):913–921. https://doi.org/10.1021/cb400841k
Lewallen DM, Bicker KL, Subramanian V, Clancy KW, Slade DJ, Martell J, Dreyton CJ, Sokolove J, Weerapana E, Thompson PR (2015) Chemical proteomic platform to identify citrullinated proteins. ACS Chem Biol 10(11):2520–2528. https://doi.org/10.1021/acschembio.5b00438
Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, Bicker KL, Bingham RP, Campbell M, Chen YH et al (2015) Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol 11(3):189–191. https://doi.org/10.1038/nchembio.1735
Lewis HD, Nacht M (2016) iPAD or PADi-’tablets’ with therapeutic disease potential? Curr Opin Chem Biol 33169-178. https://doi.org/10.1016/j.cbpa.2016.06.020
Li P, Wang D, Yao H, Doret P, Hao G, Shen Q, Qiu H, Zhang X, Wang Y, Chen G et al (2010) Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene 29(21):3153–3162. https://doi.org/10.1038/onc.2010.51
Luo Y, Arita K, Bhatia M, Knuckley B, Lee YH, Stallcup MR, Sato M, Thompson PR (2006a) Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45(39):11727–11736. https://doi.org/10.1021/bi061180d
Luo Y, Knuckley B, Bhatia M, Thompson PR (2006b) Activity based protein profiling reagents for Protein Arginine Deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently-labeled probe. J Am Chem Soc 128(45):14468–14469. https://doi.org/10.1021/ja0656907
Luo Y, Knuckley B, Lee YH, Stallcup MR, Thompson PR (2006c) A fluoro-acetamidine based inactivator of protein arginine deiminase 4 (PAD4): design, synthesis, and in vitro and in vivo evaluation. J Am Chem Soc 128(45):1092–1093. https://doi.org/10.1021/ja0576233
McElwee JL, Mohanan S, Griffith OL, Breuer HC, Anguish LJ, Cherrington BD, Palmer AM, Howe LR, Subramanian V, Causey CP et al (2012) Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 12(1):500. https://doi.org/10.1186/1471-2407-12-500
Moscarello MA, Pritzker L, Mastronardi FG, Wood DD (2002) Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 81(2): 335–343. https://doi.org/10.1191/1352458502ms776oa
Musse AA, Li Z, Ackerley CA, Bienzle D, Lei H, Poma R, Harauz G, Moscarello MA, Mastronardi FG (2008) Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 1(4–5):229–240. https://doi.org/10.1242/dmm.000729
Muth A, Subramanian V, Beaumont E, Nagar M, Kerry P, McEwan P, Srinath H, Clancy K, Parelkar S, Thompson PR (2017) Development of a selective inhibitor of protein arginine deiminase 2. J Med Chem 60(7):3198–3211. https://doi.org/10.1021/acs.jmedchem.7b00274
Nakashima K, Hagiwara T, Ishigami A, Nagata S, Asaga H, Kuramoto M, Senshu T, Yamada M (1999) Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1-alpha,25-dihydroxyvitamin D(3). J Biol Chem 274(39):27786–27792. https://doi.org/10.1074/jbc.274.39.27786
Nauseef WM, Borregaard N (2014) Neutrophils at work. Nat Immunol 15(7):602–611. https://doi.org/10.1038/ni.2921
Nemmara VV, Subramanian V, Muth A, Mondal S, Salinger AJ, Maurais AJ, Tilvawala R, Weerapana E, Thompson PR (2018) The Development of benzimidazole-based clickable probes for the efficient labeling of cellular Protein Arginine Deiminases (PADs). ACS Chem Bioldoi. https://doi.org/10.1021/acschembio.7b00957
Pritzker LB, Moscarello MA (1998) A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. Biochim Biophys Acta 1388(1):154–160. https://doi.org/10.1016/S0167-4838(98)00175-7
Qin H, Liu X, Li F, Miao L, Li T, Xu B, An X, Muth A, Thompson PR, Coonrod SA et al (2017) PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Lett 40930-41. https://doi.org/10.1016/j.canlet.2017.08.019
Raijmakers R, Zendman AJ, Egberts WV, Vossenaar ER, Raats J, Soede-Huijbregts C, Rutjes FP, van Veelen PA, Drijfhout JW, Pruijn GJ (2007) Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol 367(4):1118–1129. https://doi.org/10.1016/j.jmb.2007.01.054
Rogers G, Winter B, McLaughlan C, Powell B, Nesci T (1997) Peptidylarginine deiminase of the hair follicle: characterization, localization, and function in keratinizing tissues. J Invest Dermatol 108(5):700–707. https://doi.org/10.1111/1523-1747.ep12292083
Rogers GE, Simmonds DH (1958) Content of citrulline and other amino-acids in a protein of hair follicles. Nature 182(4629):186–187. https://doi.org/10.1038/182186a0
Saijo S, Nagai A, Kinjo S, Mashimo R, Akimoto M, Kizawa K, Yabe-Wada T, Shimizu N, Takahara H, Unno M (2016) Monomeric Form of peptidylarginine deiminase Type I revealed by X-ray crystallography and small-angle X-ray scattering. J Mol Biol 428(15):3058–3073. https://doi.org/10.1016/j.jmb.2016.06.018
Senshu T, Kan S, Ogawa H, Manabe M, Asaga H (1996) Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 225(3):712–719. https://doi.org/10.1006/bbrc.1996.1240
Slack JL, Causey CP, Luo Y, Thompson PR (2011) Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4. ACS Chem Biol 6(5):466–476. https://doi.org/10.1021/cb1003515
Slade DJ, Fang P, Dreyton CJ, Zhang Y, Fuhrmann J, Rempel D, Bax BD, Coonrod SA, Lewis HD, Guo M et al (2015) Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol 10(4):1043–1053. https://doi.org/10.1021/cb500933j
Slade DJ, Subramanian V, Thompson PR (2014) Pluripotency: citrullination unravels stem cells. Nat Chem Biol 10(5):327–328. https://doi.org/10.1038/nchembio.1504
Taki H, Gomi T, Knuckley B, Thompson PR, Vugrek O, Hirata K, Miyahara T, Shinoda K, Hounoki H, Sugiyama E et al (2011) Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms. Adv Biosci Biotechnol 02(04):304–310. https://doi.org/10.4236/abb.2011.24044
Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM (1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271(48):30709–30716. https://doi.org/10.1074/jbc.271.48.30709
Tilvawala R, Nguyen SH, Maurais AJ, Nemmara VV, Nagar M, Salinger AJ, Nagpal S, Weerapana E, Thompson PR (2018) The rheumatoid arthritis-associated citrullinome. Cell Chem Biol 25(6):691–704. https://doi.org/10.1016/j.chembiol.2018.03.002
Weerapana E, Speers AE, Cravatt BF (2007) Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)—A general method for mapping sites of probe modification in proteomes. Nat Protoc 2(6):1414–1425. https://doi.org/10.1038/nprot.2007.194
Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MB, Bachovchin DA, Mowen K, Baker D, Cravatt BF (2010) Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468(7325):790–795. https://doi.org/10.1038/nature09472
Willis VC, Banda NK, Cordova KN, Chandra PE, Robinson WH, Cooper DC, Lugo D, Mehta G, Taylor S, Tak PP et al (2017) PAD4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin Exp Immunoldoi. https://doi.org/10.1111/cei.12932
Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P et al (2011) N-alpha;-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 186(7):4396–4404. https://doi.org/10.4049/jimmunol.1001620
Witalison EE, Thompson PR, Hofseth LJ (2015) Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation. Curr Drug Targets 16(7):700–710. https://doi.org/10.2174/1389450116666150202160954
Zhang X, Bolt M, Guertin MJ, Chen W, Zhang S, Cherrington BD, Slade DJ, Dreyton CJ, Subramanian V, Bicker KL et al (2012) Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation. Proc Natl Acad Sci U S A 10913331–13336. https://doi.org/10.1073/pnas.1203280109
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nemmara, V.V., Thompson, P.R. (2018). Development of Activity-Based Proteomic Probes for Protein Citrullination. In: Cravatt, B., Hsu, KL., Weerapana, E. (eds) Activity-Based Protein Profiling. Current Topics in Microbiology and Immunology, vol 420. Springer, Cham. https://doi.org/10.1007/82_2018_132
Download citation
DOI: https://doi.org/10.1007/82_2018_132
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11142-7
Online ISBN: 978-3-030-11143-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)